South Korea Antibiotic Resistance Market Size & Outlook
South Korea antibiotic resistance market, 2018-2030 (US$M)
Related Markets
South Korea antibiotic resistance market highlights
- The South Korea antibiotic resistance market generated a revenue of USD 28.3 million in 2023 and is expected to reach USD 43.8 million by 2030.
- The South Korea market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, cuti was the largest revenue generating disease in 2023.
- CDI is the most lucrative disease segment registering the fastest growth during the forecast period.
Antibiotic resistance market data book summary
| Market revenue in 2023 | USD 28.3 million |
| Market revenue in 2030 | USD 43.8 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Cuti |
| Fastest growing segment | CDI |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CUTI, CDI, ABSSSI, HABP, CABP, CIAI, BSI |
| Key market players worldwide | Melinta Therapeutics, Basilea Pharmaceutica Ltd, Theravance Biopharma Inc, Seres Therapeutics Inc, AbbVie Inc, Merck & Co Inc, Hubsan, Wockhardt, Entasis Therapeutics, Tetraphase Pharmaceuticals, Paratek Pharmaceuticals, Axogen Inc |
Other key industry trends
- In terms of revenue, South Korea accounted for 0.3% of the global antibiotic resistance market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China antibiotic resistance market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 850.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antibiotic Resistance Market Scope
Antibiotic Resistance Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea antibiotic resistance market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antibiotic resistance market will help companies and investors design strategic landscapes.
Cuti was the largest segment with a revenue share of 24.73% in 2023. Horizon Databook has segmented the South Korea antibiotic resistance market based on cuti, cdi, absssi, habp, cabp, ciai, bsi covering the revenue growth of each sub-segment from 2018 to 2030.
- South Korea Antibiotic Resistance Disease Outlook (Revenue, USD Million, 2018-2030)
- cUTI
- CDI
- ABSSSI
- HABP
- CABP
- cIAI
- BSI
- South Korea Antibiotic Resistance Pathogen Outlook (Revenue, USD Million, 2018-2030)
- E.coli
- klebsiella pneumoniae
- P. aeruginosa
- S. aureus
- A. baumannii
- Strep. Pneumoniae
- H. influenzae
- CDI
- Enterococcus fecium
- South Korea Antibiotic Resistance Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Combination therapies
- Cephalosporins
- Other drug classes
- South Korea Antibiotic Resistance Mechanism of Action Outlook (Revenue, USD Million, 2018-2030)
- Protein Synthesis Inhibitors
- Cell Wall Synthesis Inhibitors
- RNA Synthesis Inhibitors
- DNA Synthesis Inhibitors
- Other mechanism of actions
- South Korea Antibiotic Resistance Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Reasons to subscribe to South Korea antibiotic resistance market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea antibiotic resistance market databook
-
Our clientele includes a mix of antibiotic resistance market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea antibiotic resistance market , including forecasts for subscribers. This country databook contains high-level insights into South Korea antibiotic resistance market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea antibiotic resistance market size, by disease, 2018-2030 (US$M)
South Korea Antibiotic Resistance Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
